STORY FROM: Drugs & Medical Devices
Learned Intermediary Doctrine Bars Amiodarone Warning Claims, 4th Cir. Rules
April 10, 2019
RICHMOND, Va. — The learned intermediary doctrine defeats claims that the manufacturers of generic Cordarone failed to properly warn of its risks because the prescribing physician was aware of the drug’s side effects, a federal appeals court has ruled.
In an April 8 opinion, the 4th Circuit U.S. Court of Appeals concluded that the drug maker defendants fulfilled their state-law duty to warn the prescribing doctor of the risk of pulmonary toxicity.
Hubert E. Bean Jr. was prescribed Cordarone (amiodarone) to treat his non-life-threatening atrial fibrillation. There is no dispute that, at the time of the prescription, Bean’s physician, ...
Associated Law Firms
White & Boyd
Wood Law Firm